Literature DB >> 17355453

MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure.

Aezam Katoonizadeh1, Jochen Decaestecker, Alexander Wilmer, Raymond Aerts, Chris Verslype, Werner Vansteenbergen, Paul Yap, Johan Fevery, Tania Roskams, Jacques Pirenne, Frederik Nevens.   

Abstract

AIMS/
BACKGROUND: A model for end stage liver disease (MELD) score >30 was proposed as an excellent predictor of mortality in patients with non-acetaminophen-induced acute liver failure (ALF). We analyzed the prognostic value of MELD score in our patients with ALF who were prospectively registered in our database since 1990.
METHODS: Overall, 106 patients met the criteria of ALF. Excluding seven patients with acetaminophen etiology, 99 patients (42+/-15 years, 40M/59F) were studied.
RESULTS: Causes were cryptogenic (n=38), viral (n=29), drugs (n=20) and miscellaneous (n=12). Of these, 37% (n=37) survived with medical management alone (group I), 16% (n=16) died (group II) and 46% (n=46) underwent liver transplantation (group III). The strongest predictors of poor outcome were advanced encephalopathy, cryptogenic/drug-induced/hepatitis B etiology and a high MELD score. At the time of diagnosis, King's College Hospital criteria and MELD score >30 had similar high negative predictive value (92% and 91%, respectively) and low positive predictive value (52% and 56%, respectively). The predictive values improved only slightly during follow-up. The best cut-off point for MELD score to discriminate between survivors and nonsurvivors was >35, with a sensitivity and specificity of 86% and 75%, respectively.
CONCLUSIONS: MELD score, which mostly takes into consideration the degree of liver impairment, has a similar prognostic value as King's College Hospital criteria to predict outcome in adult patients with nonacetaminophen-induced ALF. Overall, all current scores miss accuracy and therefore there is a clear need for factors that can better predict the regeneration of the liver in this setting.

Entities:  

Mesh:

Year:  2007        PMID: 17355453     DOI: 10.1111/j.1478-3231.2006.01429.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  23 in total

1.  Development of a Model to Predict Transplant-free Survival of Patients With Acute Liver Failure.

Authors:  David G Koch; Holly Tillman; Valerie Durkalski; William M Lee; Adrian Reuben
Journal:  Clin Gastroenterol Hepatol       Date:  2016-04-13       Impact factor: 11.382

Review 2.  Model for End-stage Liver Disease.

Authors:  Ashwani K Singal; Patrick S Kamath
Journal:  J Clin Exp Hepatol       Date:  2012-12-01

Review 3.  Neurological management of fulminant hepatic failure.

Authors:  Jennifer A Frontera; Thomas Kalb
Journal:  Neurocrit Care       Date:  2011-04       Impact factor: 3.210

Review 4.  [Acute liver failure. How much diagnostic work-up and therapy does my patient need?].

Authors:  J Hadem; A S Schneider; M P Manns
Journal:  Internist (Berl)       Date:  2011-07       Impact factor: 0.743

5.  Auxiliary partial liver transplantation for acute liver failure using "high risk" grafts: Case report.

Authors:  Wei-Dong Duan; Xi-Tao Wang; Hong-Guang Wang; Wen-Bin Ji; Hao Li; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2016-02-07       Impact factor: 5.742

Review 6.  Recent developments in acute liver failure.

Authors:  William M Lee
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-02       Impact factor: 3.043

7.  A new prognostic formula for adult acute liver failure using computer tomography-derived hepatic volumetric analysis.

Authors:  Yoshiyuki Yamagishi; Hidetsugu Saito; Hirotoshi Ebinuma; Masahiro Kikuchi; Keisuke Ojiro; Hideaki Kanamori; Shinichiro Tada; Yoshinori Horie; Shinzo Kato; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2009-04-17       Impact factor: 7.527

8.  Evaluation of a scoring system for assessing prognosis in pediatric acute liver failure.

Authors:  Brandy R Lu; Jane Gralla; Edwin Liu; Emily L Dobyns; Michael R Narkewicz; Ronald J Sokol
Journal:  Clin Gastroenterol Hepatol       Date:  2008-10       Impact factor: 11.382

9.  Immunophenotype predicts outcome in pediatric acute liver failure.

Authors:  John Bucuvalas; Lisa Filipovich; Nada Yazigi; Michael R Narkewicz; Vicky Ng; Steven H Belle; Song Zhang; Robert H Squires
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-03       Impact factor: 2.839

10.  Role of N-acetylcysteine in adults with non-acetaminophen-induced acute liver failure in a center without the facility of liver transplantation.

Authors:  Khalid Mumtaz; Zahid Azam; Saeed Hamid; Shahab Abid; Sadik Memon; Hasnain Ali Shah; Wasim Jafri
Journal:  Hepatol Int       Date:  2009-08-29       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.